- Home
- ZUMZ vs CVRX Comparison
ZUMZ vs CVRX Comparison
Compare ZUMZ & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZUMZ
- CVRX
- Stock Information
- Founded
- ZUMZ 1978
- CVRX 2000
- Country
- ZUMZ United States
- CVRX United States
- Employees
- ZUMZ N/A
- CVRX N/A
- Industry
- ZUMZ Clothing/Shoe/Accessory Stores
- CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ZUMZ Consumer Discretionary
- CVRX Health Care
- Exchange
- ZUMZ Nasdaq
- CVRX Nasdaq
- Market Cap
- ZUMZ 211.6M
- CVRX 174.4M
- IPO Year
- ZUMZ 2005
- CVRX 2021
- Fundamental
- Price
- ZUMZ $13.44
- CVRX $6.86
- Analyst Decision
- ZUMZ Hold
- CVRX Buy
- Analyst Count
- ZUMZ 1
- CVRX 7
- Target Price
- ZUMZ $25.00
- CVRX $14.50
- AVG Volume (30 Days)
- ZUMZ 261.3K
- CVRX 171.6K
- Earning Date
- ZUMZ 09-04-2025
- CVRX 07-28-2025
- Dividend Yield
- ZUMZ N/A
- CVRX N/A
- EPS Growth
- ZUMZ N/A
- CVRX N/A
- EPS
- ZUMZ 0.04
- CVRX N/A
- Revenue
- ZUMZ $896,157,000.00
- CVRX $52,870,000.00
- Revenue This Year
- ZUMZ $3.31
- CVRX $11.53
- Revenue Next Year
- ZUMZ $1.34
- CVRX $18.61
- P/E Ratio
- ZUMZ $345.43
- CVRX N/A
- Revenue Growth
- ZUMZ 3.01
- CVRX 25.62
- 52 Week Low
- ZUMZ $11.31
- CVRX $4.30
- 52 Week High
- ZUMZ $31.37
- CVRX $18.55
- Technical
- Relative Strength Index (RSI)
- ZUMZ 52.63
- CVRX 61.51
- Support Level
- ZUMZ $13.57
- CVRX $6.30
- Resistance Level
- ZUMZ $14.38
- CVRX $7.21
- Average True Range (ATR)
- ZUMZ 0.63
- CVRX 0.35
- MACD
- ZUMZ 0.04
- CVRX 0.16
- Stochastic Oscillator
- ZUMZ 48.36
- CVRX 83.24
About ZUMZ Zumiez Inc.
Zumiez Inc is a United-States-based specialty retailer engaged in the sale of apparel, footwear, accessories, and hard goods. The company provides merchandise with cultural elements coming from fashion, music, art from action sports, streetwear, and other lifestyles. The company operates under the brands Zumiez, Fast Times, and Blue Tomato, and through both physical stores and websites. The majority of the company's stores are located in the U.S., with the rest in Canada, Australia, and Europe. The U.S. market contributes to the majority of the company's revenue.
About CVRX CVRx Inc.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.